InsidersTradesSigma
Discover the detailed record of transactions filed by COOPER WARREN D, Director. Director active across 1 companies, notably Zynerba Pharmaceuticals, Inc.. In total, 3 disclosures have been recorded. The latest transaction was disclosed on 14 June 2022 (Attribution). Regulator: SEC (Form 4). All data is free.
3 of 3 declarations
Warren D. Cooper is a Board Member at Zynerba Pharmaceuticals, Inc. He is involved in governance and strategic decision-making. With expertise in the pharmaceutical sector, Warren contributes to innovation and growth within the company.